Dr. Hutton is an assistant professor of health management and policy in the School of Public Health who focuses on health policy modeling and cost-effectiveness analysis.
Economics of Eye Care
Economics of Eye Care researchers at the Kellogg Eye Center are working to make the delivery of eye care more efficient and cost-effective.
Dr. Shtein is a cornea specialist interested in the cost-effectiveness of different treatments for corneal disease.
Dr. De Lott is a neuro-ophthalmologist who focuses her research on resource utilization and telemedicine approaches to early, remote diagnosis of optic nerve and eye movement disorders
Dr. Stein is a glaucoma specialist with expertise in research using large data sets to understand important associations with ocular diseases and to study the economics of eye care.
In the News
The biologic drugs bevacizumab and ranibizumab have revolutionized treatment of diabetic macular edema and neovascular age-related macular degeneration.
PURPOSE: We sought to determine the most cost-effective treatment for patients with newly diagnosed neovascular macular degeneration: monthly or as-needed bevacizumab injections, o
OBJECTIVE: Anti–vascular endothelial growth factor therapies have revolutionized the treatment of clinically significant diabetic macular edema (CSDME); yet these agents are expens
PURPOSE: To perform a comparative cost-effectiveness analysis of Descemet stripping automated endothelial keratoplasty (DSAEK) and penetrating keratoplasty (PK) for corneal endothe
OBJECTIVE: To determine the most cost-effective treatment option for patients with newly diagnosed mild open-angle glaucoma: observation only, treatment with generic topical prosta